LIU XIAODONG,LI XIAOLIN,LOREN JON,MOLTENI VALENTINA,NABAKKA JULIET,NGUYEN BAO,PETRASSI HANK MICHAEL JAMES,YEH VINCE
申请号：
IN1251/DELNP/2014
公开号：
IN2014DN01251A
申请日:
2014.02.19
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof which are useful as protein kinase inhibitors as well as methods for using such compounds to treat ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments the invention provides methods for using such compounds to treat ameliorate or prevent diseases or disorders that involve abnormal activation of c kit or c kit and PDGFR (PDGFRa PDGFR) kinases.
